All the Active Ingredient Drugs
Corticosteroid, Vitamin D Analog. Calcipotriol 50 mcg/g, Betamethasone (as dipropionate) 0.5 mg/g. Oint:30/60/120 g. Apply to affected area once daily. The recomm. tmt. period is 4 wks. There is experience with repeated courses up to 52 w ks. If it is necessary to cont. or restart tmt. after 4 wks., tmt. should be cont. after med. review and under regular med. supervis.
When using calcipotriol contain. med. products, the max. dly. dose should not exceed 15 g. The body surface area treated with calcipotriol contain. drugs should not exceed 30% . See lit.
Topical treatment of stable plaque
psoriasis vulgaris amenable to topical
therapy. For renal /hepatic impair. and ped. pop. see lit.
C/I: Hypersens. Pts with erythrodermic, exfoliative and pustular psoriasis.
Pts. with known disorders of calcium metabolism .
Pts. with viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.
Corticosteroid, Vitamin D Analog. Betamethasone (as dipropionate) 0.5 mg/g, Calcipotriol (as hydrate) 50 mcg/g. OINT.: 30, 60gr. Oint. should be applied to the affect. area once dly.
The recomm. tmt. period is 4 wks. There is experience with repeated courses of Daivobet up to 52 w ks. If it is necessary to cont. or restart tmt. after 4 wks., tmt. should be cont.after med.review and under regular med. supervis.
When using calcipotriol contain. med. products, the max. dly. dose should not exceed 15 g. The body surface area treated with calcipotriol contain. med. products should not exceed 30% . See lit.
Topical tmt. of stable plaque psoriasis vulgaris amenable to topical ther.
C/I: Hypersens.
Pts with erythrodermic, exfoliative and pustular psoriasis.
Pts. with known disorders of calcium metabolism .
Pts. with viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.
Antipsoriatics. Betamethasone (as dipropionate) 0.5 mg / 1 g, Calcipotriol (as hydrate) 50 mcg / 1 g. Gel: Bottle- 30 g, 60 g.
Xamiol gel should be appl. to affect. areas once dly. The recomm. tmt. period is 4 wks for scalp areas and 8 wks for “non-scalp” areas. If it is necessary to contin. or restart tmt. after this period, tmt. should be contin. after med. review and under regular med. supervis. When using calcipotriol contain. products, the max. dly. dose should not exceed 15 g. The body surface area treat. with calcipotriol contain. products should not exceed 30%. If used on the scalp: All the affected scalp areas may be treat. with Xamiol. Usual. an amount between 1g - 4g /d is suffic. for tmt. of the scalp (4 g corresp. to one teaspn). See lit.
Topical tmt. of psoriasis vulgaris on the scalp and topical tmt. of mild to moder. “non-scalp” plaque psoriasis vulgaris in adults 18 yrs. of age and older.
C/I: Hypersens. to the active substances or to any of the excipients.
Pts. with erythrodermic, exfoliative & pustular psoriasis.
Pts. with known disorders of calcium metabolism.
Pts. With Viral (e.g. herpes or varicella) lesions of the skin, fung./bact. skin infec., parasitic infec., skin manifestat. in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers, wounds. See lit.
